Super Vilitra

Description

ED and premature ejaculation don't always arrive separately. For a significant number of Canadian men, they show up together — and that combination is harder to manage than either condition on its own. You're dealing with difficulty achieving or maintaining an erection, and when you do get there, the ejaculatory control piece falls apart. Two different problems, two different failure points, two layers of pressure on something that should feel natural.

Super Vilitra is a combination tablet specifically formulated for this situation. Each tablet contains Vardenafil 20 mg — the same active ingredient in brand Levitra — and Dapoxetine 60 mg, a short-acting compound developed specifically for premature ejaculation. Manufactured by Centurion Laboratories, it addresses both conditions simultaneously through two distinct pharmacological mechanisms working in parallel.

This isn't two separate medications swallowed at the same time. It's a single formulated tablet designed so both ingredients absorb together and reach therapeutic effect within the same window.

Understanding the Two Conditions Super Vilitra Targets

Before getting into how the medication works, it's worth being clear on what it's treating — because ED and PE are physiologically distinct conditions that happen to co-occur frequently.

Erectile Dysfunction: is a vascular and neurological problem. The blood flow response to sexual arousal is insufficient — either because the vessels don't dilate adequately, the nerve signals are interrupted, or the muscle relaxation in penile tissue is impaired. The result is an erection that doesn't form properly, doesn't maintain firmness, or loses rigidity before ejaculation occurs.

Premature Ejaculation: is primarily a central nervous system regulation problem. Ejaculation happens through a spinal reflex that's modulated by serotonin pathways in the brain — specifically, higher serotonin activity at certain receptors correlates with delayed ejaculation, and lower activity correlates with reduced control. Men with PE typically have a lower ejaculatory threshold — the reflex fires too quickly regardless of intent.

These two conditions amplify each other psychologically. ED creates performance anxiety, which can trigger PE. PE creates anticipatory anxiety about control, which worsens the erectile response. Managing one while the other is still present often leaves men feeling only partially improved. Super Vilitra targets both at the pharmacological level simultaneously.

How Each Ingredient Works

Vardenafil 20 mg — Handling the Erectile Side

Vardenafil belongs to the PDE5 inhibitor class. During sexual arousal, the body releases nitric oxide in penile tissue, which triggers production of cyclic GMP — a signalling molecule that causes smooth muscle in blood vessel walls to relax and dilate, allowing blood to fill the erectile chambers.

PDE5 is the enzyme that degrades cGMP, ending the erection signal. In men with ED, this enzyme is overactive or the erectile response is otherwise insufficient. Vardenafil selectively blocks PDE5, allowing cGMP to accumulate and the blood flow response to proceed more fully and last longer.

At 20 mg — the maximum standard on-demand dose — Vardenafil's PDE5 inhibition is at its strongest clinical level. For men with moderate-to-severe ED, this is typically the dose that produces a clinically adequate response where lower doses may fall short.

Dapoxetine 60 mg — Handling the Premature Ejaculation Side

Dapoxetine is pharmacologically an SSRI — a selective serotonin reuptake inhibitor — but unlike antidepressants in the same class (which are taken daily and build effect over weeks), Dapoxetine was specifically engineered for on-demand use. It's rapidly absorbed, reaches peak plasma concentration within 60 to 90 minutes, and is cleared from the body within hours. This pharmacokinetic profile makes it suitable as a take-before-sex medication rather than a daily treatment.

Its mechanism: it inhibits the reuptake of serotonin at synaptic junctions in the neural pathways controlling ejaculation. More serotonin stays active at relevant receptors. The ejaculatory reflex threshold is raised. Ejaculation is delayed — typically by two to three times the baseline intravaginal ejaculatory latency time (IELT) in clinical studies, and often meaningfully longer in practice.

The 60 mg dose is the higher of the two available Dapoxetine strengths (30 mg and 60 mg). It's typically used when the 30 mg dose has been tried and found insufficient, or when a prescriber determines 60 mg is appropriate for the degree of PE being treated.

The Timing Question — What Most Pages Don't Tell You

This is where Super Vilitra gets practically complex, and where competitor pages consistently fall short of giving patients useful information.

Vardenafil and Dapoxetine have different absorption and onset profiles:

• Vardenafil reaches therapeutic blood levels in roughly 30 to 60 minutes, with peak plasma concentration around 60 minutes post-dose
• Dapoxetine absorbs slightly faster — noticeable effect can begin within 30 minutes, with peak concentration at 60 to 90 minutes

In a combination tablet, both are absorbed together. The practical implication: take Super Vilitra approximately 60 minutes before sexual activity for both components to be in their optimal therapeutic window simultaneously. The 30-minute guideline sometimes cited for Vardenafil alone is less reliable when Dapoxetine's slightly slower peak is factored in.

Additional timing considerations:

• Take with water, with or without food — but avoid a very large high-fat meal immediately before, as fatty food can slow absorption of both components
• Avoid grapefruit and grapefruit juice on the day of dosing — grapefruit inhibits CYP3A4, the liver enzyme that metabolises Vardenafil, and can unpredictably raise drug levels
• One tablet per 24 hours — the combination of two active ingredients means that doubling up carries a meaningfully higher risk than taking extra of either ingredient alone
• Alcohol caution is particularly important with Super Vilitra. Dapoxetine on its own already has CNS effects that alcohol compounds — combining the two increases risk of dizziness, fainting, and drowsiness beyond what either causes alone. Keep alcohol minimal or avoid it entirely on days you take Super Vilitra

Is Super Vilitra the Right Choice, or Should You Take Separate Medications?

A fair question. Some men prefer to manage ED and PE with separate medications, taken at different times or adjusted independently. Others find the combination tablet more practical.

Super Vilitra makes more clinical sense when:

• Both conditions are confirmed to be present and need simultaneous treatment
• Your doctor has assessed the appropriate doses for each and determined that Vardenafil 20 mg and Dapoxetine 60 mg specifically are what's needed — not a lower dose of either
• Simplicity matters — one tablet at one time is easier to manage consistently than two separate medications with potentially different dosing instructions
• You've already tried standalone Vardenafil and found the ED component is handled well at 20 mg, but PE remains an issue

Separate medications may be more appropriate when:

• You need the flexibility to dose each component differently — for example, Vardenafil 10 mg works for ED but you want to trial Dapoxetine 30 mg before committing to 60 mg
• One condition resolves and you want to continue treating only the other
• Side effects from one ingredient require adjustment without changing the other

This is ultimately a clinical conversation with your prescribing doctor, not a self-selection decision. Both pathways are valid — the combination tablet is a convenience and pharmacological efficiency play, not necessarily superior to optimised individual treatment.

Side Effects — Separated by Ingredient for Clarity

Because Super Vilitra contains two distinct active ingredients, understanding which side effects come from which component helps make sense of what you might experience.

From Vardenafil 20 mg (PDE5 inhibitor effects):

• Headache — most commonly reported; related to vasodilation; usually responds to hydration
• Facial flushing or warmth, particularly cheeks and neck
• Nasal congestion or runny nose
• Indigestion or mild acid reflux
• Dizziness, especially on standing up quickly
• Back pain or muscle aches — characteristic of Vardenafil; typically appears 12-24 hours post-dose and resolves without intervention

From Dapoxetine 60 mg (SSRI-class effects):

• Nausea — the most commonly reported Dapoxetine side effect; usually mild and temporary, often improves after the first few uses
• Dry mouth
• Headache (this overlaps with Vardenafil, so headache at any point after taking Super Vilitra is likely from both)
• Drowsiness or fatigue — more characteristic of Dapoxetine than Vardenafil; another reason to be cautious about alcohol
• Diarrhoea in some patients, particularly early in use
• Insomnia or sleep disturbance if the medication is taken too close to bedtime

Serious — stop use and seek immediate medical attention:

• Priapism — erection lasting more than four hours. A urological emergency, pain or no pain
• Sudden vision loss or significant visual disturbance
• Sudden hearing loss or tinnitus
• Syncope (fainting) — more of a risk with Super Vilitra than with either ingredient alone, particularly combined with alcohol or alpha-blockers
• Chest pain or cardiac symptoms during or after sexual activity
• Signs of serotonin syndrome — agitation, rapid heart rate, high temperature, tremor, confusion. Rare, but possible if Super Vilitra is taken alongside other serotonergic medications (antidepressants, triptans, lithium, tramadol)

Warnings and Contraindications

Nitrate medications — absolute contraindication. Any form of nitrate used for chest pain (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) combined with Vardenafil carries serious blood pressure drop risk. This contraindication carries the same weight as with standalone Vardenafil. Recreational nitrates (poppers) carry identical risk.

Serotonergic medications — serious interaction with Dapoxetine. Men taking antidepressants, particularly SSRIs, SNRIs, or MAOIs, should not take Super Vilitra without explicit guidance from their prescribing psychiatrist or doctor. Combining multiple serotonergic agents raises the risk of serotonin syndrome, which can be severe. This interaction is the most Super Vilitra-specific warning that doesn't exist with standalone Vardenafil products.

MAOIs specifically: Do not take Super Vilitra within 14 days of stopping a monoamine oxidase inhibitor. The interaction risk is serious enough that this is a hard clinical rule, not a caution.

Alpha-blockers: The blood pressure-lowering interaction between Vardenafil and alpha-blockers (tamsulosin, doxazosin) requires careful management. With Super Vilitra, Dapoxetine adds a further hypotensive risk — the combined drop can be clinically significant.

Liver disease: Both Vardenafil and Dapoxetine are hepatically metabolised. Moderate hepatic impairment limits Vardenafil to a maximum of 10 mg — Super Vilitra at 20 mg/60 mg is not appropriate in this context. Severe hepatic impairment is a contraindication for both components.

Driving and operating machinery: Dapoxetine specifically lists dizziness and syncope as risks that affect driving ability. Men should be aware of how Super Vilitra affects them before operating vehicles, particularly on first use.

Not appropriate for: Women, patients under 18, men over 65 without specific medical assessment (both Vardenafil and Dapoxetine have modified pharmacokinetics in older patients), men with a history of mania or severe depression (Dapoxetine's SSRI mechanism requires caution in these populations).